Muvalaplin reduces lipoprotein(a) levels, according to a study published online Nov. 20 in the Journal of the American ...

Bones can weaken with age and osteoporosis is common, but the right meds and lifestyle changes can keep bones strong.

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...